TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bioglan AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
25,884
|
20,325
|
16,284 |
| Financial expenses |
59
|
82
|
72 |
| Earnings before taxes |
3,428
|
2,676
|
951 |
| EBITDA |
3,792
|
3,332
|
1,477 |
| Total assets |
24,729
|
20,658
|
16,970 |
| Current assets |
16,645
|
13,395
|
10,945 |
| Current liabilities |
10,366
|
8,598
|
7,027 |
| Equity capital |
14,363
|
12,060
|
9,943 |
| - share capital |
261
|
270
|
270 |
| Employees (average) |
113
|
102
|
101 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
58.1%
|
58.4%
|
58.6% |
| Turnover per employee |
229
|
199
|
161 |
| Profit as a percentage of turnover |
13.2%
|
13.2%
|
5.8% |
| Return on assets (ROA) |
14.1%
|
13.4%
|
6.0% |
| Current ratio |
160.6%
|
155.8%
|
155.8% |
| Return on equity (ROE) |
23.9%
|
22.2%
|
9.6% |
| Change turnover |
6,250
|
3,994
|
1,786 |
| Change turnover % |
32%
|
24%
|
12% |
| Chg. No. of employees |
11
|
1
|
7 |
| Chg. No. of employees % |
11%
|
1%
|
7% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.